Literature DB >> 18998056

Expression of HIF-1, galectin-3, cox-2 and Wilms tumor-1 protein in multiple schwannomas of the conus medullaris.

Amr M Sarwat1, Suhail Al-Salam.   

Abstract

Schwannomatosis is a clinical syndrome that requires thorough clinical and radiological assessments before the diagnosis is made. Although schwannomatosis has been reported before, all were in multiple organ sites. The authors report a case of multiple intra-dural schwannomas of the conus medullaris expressing HIF-1, galectin-3, cox-2 and Wilms tumor-1 protein; which to the best of our knowledge has not been previously reported in schwanomatosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18998056     DOI: 10.1007/s11060-008-9729-8

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  17 in total

1.  Up-regulation of gene expression by hypoxia is mediated predominantly by hypoxia-inducible factor 1 (HIF-1).

Authors:  A E Greijer; P van der Groep; D Kemming; A Shvarts; G L Semenza; G A Meijer; M A van de Wiel; J A M Belien; P J van Diest; E van der Wall
Journal:  J Pathol       Date:  2005-07       Impact factor: 7.996

Review 2.  Galectins. Structure and function of a large family of animal lectins.

Authors:  S H Barondes; D N Cooper; M A Gitt; H Leffler
Journal:  J Biol Chem       Date:  1994-08-19       Impact factor: 5.157

3.  The Wilms tumor suppressor WT1 encodes a transcriptional activator of amphiregulin.

Authors:  S B Lee; K Huang; R Palmer; V B Truong; D Herzlinger; K A Kolquist; J Wong; C Paulding; S K Yoon; W Gerald; J D Oliner; D A Haber
Journal:  Cell       Date:  1999-09-03       Impact factor: 41.582

4.  Cyclooxygenase-2 increases hypoxia-inducible factor-1 and vascular endothelial growth factor to promote angiogenesis in gastric carcinoma.

Authors:  Shih-Pei Huang; Ming-Shiang Wu; Chia-Tung Shun; Hsiu-Po Wang; Chang-Yao Hsieh; Min-Liang Kuo; Jaw-Town Lin
Journal:  J Biomed Sci       Date:  2005       Impact factor: 8.410

5.  HIF-1 alpha is a regulator of galectin-3 expression in the intervertebral disc.

Authors:  Yan Zeng; Keith G Danielson; Todd J Albert; Irving M Shapiro; Makarand V Risbud
Journal:  J Bone Miner Res       Date:  2007-12       Impact factor: 6.741

6.  Multiple schwannomas: schwannomatosis or neurofibromatosis type 2?

Authors:  M T Seppälä; M A Sainio; M J Haltia; J J Kinnunen; K H Setälä; J E Jääskeläinen
Journal:  J Neurosurg       Date:  1998-07       Impact factor: 5.115

7.  Neurofibromatosis 2 and neurilemmomatosis gene are identical.

Authors:  M Honda; E Arai; S Sawada; A Ohta; M Niimura
Journal:  J Invest Dermatol       Date:  1995-01       Impact factor: 8.551

8.  Long-term outcome after removal of spinal schwannoma: a clinicopathological study of 187 cases.

Authors:  M T Seppälä; M J Haltia; R J Sankila; J E Jääskeläinen; O Heiskanen
Journal:  J Neurosurg       Date:  1995-10       Impact factor: 5.115

9.  Solitary benign peripheral-nerve tumours. Review of 32 years' experience.

Authors:  N J Kehoe; R P Reid; J C Semple
Journal:  J Bone Joint Surg Br       Date:  1995-05

10.  Are acoustic neuromas encapsulated tumors?

Authors:  T C Kuo; R K Jackler; K Wong; N H Blevins; L H Pitts
Journal:  Otolaryngol Head Neck Surg       Date:  1997-12       Impact factor: 5.591

View more
  2 in total

1.  Wilms tumor-1, claudin-1 and ezrin are useful immunohistochemical markers that help to distinguish schwannoma from fibroblastic meningioma.

Authors:  Avninder Singh; Ashwani Kumar Mishra; Kris Ylaya; Stephen M Hewitt; Karam Chand Sharma; Sunita Saxena
Journal:  Pathol Oncol Res       Date:  2011-09-10       Impact factor: 3.201

2.  Hypoxia potentiates glioma-mediated immunosuppression.

Authors:  Jun Wei; Adam Wu; Ling-Yuan Kong; Yongtao Wang; Gregory Fuller; Isabella Fokt; Giovanni Melillo; Waldemar Priebe; Amy B Heimberger
Journal:  PLoS One       Date:  2011-01-20       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.